Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
75.51M | 83.14M | 52.52M | 113.97M | 99.48M | Gross Profit |
20.74M | 14.68M | 10.83M | 41.73M | 38.58M | EBIT |
-53.39M | -9.59M | -54.57M | -41.73M | -49.15M | EBITDA |
-74.79M | -4.51M | -61.82M | -29.28M | -25.02M | Net Income Common Stockholders |
-47.43M | -7.29M | -87.35M | -53.52M | -77.28M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
152.56M | 263.55M | 164.96M | 318.68M | 147.81M | Total Assets |
3.20B | 1.83B | 1.98B | 2.77B | 2.84B | Total Debt |
90.49M | 115.50M | 141.74M | 178.95M | 497.97M | Net Debt |
-56.77M | -142.57M | -21.21M | -118.24M | 350.16M | Total Liabilities |
474.25M | 334.40M | 362.69M | 545.67M | 904.76M | Stockholders Equity |
2.73B | 1.49B | 1.62B | 2.22B | 1.94B |
Cash Flow | Free Cash Flow | |||
0.00 | -52.68M | -92.82M | 82.82M | -10.62M | Operating Cash Flow |
-80.87M | -43.59M | -77.91M | 105.22M | 3.40M | Investing Cash Flow |
0.00 | 43.10M | -104.25M | 369.21M | -64.92M | Financing Cash Flow |
0.00 | -22.38M | -23.79M | -325.97M | -42.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $193.58B | 17.73 | 5.39% | 0.40% | 2.02% | 7.93% | |
76 Outperform | HK$531.99B | 37.54 | 27.96% | 2.37% | 19.20% | 24.01% | |
74 Outperform | $159.37B | 13.19 | 11.39% | 2.93% | -2.65% | -14.96% | |
66 Neutral | $4.52B | 12.34 | 5.41% | 3.62% | 4.15% | -12.18% | |
43 Neutral | $5.02B | ― | -4.20% | 0.70% | -10.06% | 86.09% | |
42 Neutral | HK$1.16B | ― | ― | ― | ― | ||
41 Neutral | HK$800.40M | ― | -2.25% | ― | -9.17% | -547.06% |
KuangChi Science Limited has announced the availability of its 2024 Annual Report on its website and the Hong Kong Stock Exchange’s website. The company encourages shareholders to access the report online to stay informed about corporate communications. Shareholders who prefer printed versions can request them through the company’s branch share registrar. This move underscores the company’s commitment to transparency and efficient communication with its stakeholders.
KuangChi Science Limited has announced the availability of its 2024 Annual Report in both English and Chinese on its website and the Hong Kong Stock Exchange’s website. The company is encouraging non-registered holders to access these documents online but offers the option to receive printed versions upon request. This move reflects the company’s commitment to providing accessible corporate communications to its stakeholders, potentially enhancing transparency and engagement with its investors.
KuangChi Science Limited announced that its controlling shareholder, New Horizon Wireless Communication Limited, has sold 178,550,936 shares, representing approximately 29% of the company’s total issued shares, to an independent third-party investor. This transaction significantly reduces the controlling shareholder’s stake, impacting the company’s shareholding structure while maintaining Dr. Liu Ruopeng’s position as a substantial shareholder through indirect interests.
KuangChi Science Limited announced its audited consolidated financial results for the year ended December 31, 2024, reporting a decrease in revenue from HK$83,139,000 in 2023 to HK$75,514,000 in 2024. Despite an increase in gross profit and other income, the company faced a significant operating loss due to higher research and development expenses, leading to a net loss of HK$47,427,000 for the year. This financial performance reflects challenges in cost management and market conditions, impacting the company’s profitability and stakeholder interests.
KuangChi Science Limited has announced a change in its Hong Kong share registrar and transfer office, effective from April 1, 2025. The new registrar will be Tricor Investor Services Limited, and all applications for registration of share transfers should be directed to them from this date. This change may streamline the company’s share management processes and potentially impact shareholder interactions.